India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
Vision impairment: Say goodbye to glasses with the latest treatment About 30 percent of people with vision impairment in Nepal do not wear glasses, which affects their employment and self-confidence. There are three main methods of correcting vision impairment by reducing the power of the pupil of the eye using laser technology: photorefractive keratectomy, LASIK, and SMILE. Laser surgery is suitable for patients over 18 years of age with stable power and has a 95 to 98 percent success rate. Look at the eyes of people you walk by. About 3 out of every 10 people are found wearing glasses. It is said that where there is a virtue, there is also a defect. Perhaps the defect of such a convenient world is vision impairment. Continuous close work, excessive and continuous use of screens are increasing the risk of vision impairment. Despite having vision problems, almost half of people who should wear glasses are not wearing glasses. Some are unaware of their vision impairment, while othe...